FDA Inspection 1285906 — Centrient Pharmaceuticals Spain S.A.
The FDA completed an inspection of Centrient Pharmaceuticals Spain S.A. on May 30, 2024 in Santa Perpetua De Mogoda. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- May 30, 2024
- Fiscal Year
- 2024
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Santa Perpetua De Mogoda (Spain)
Additional Details
Mutual Recognition Agreement (MRA)